Christopher Dockendorff PhD

Dr. Christopher Dockendorff is an organic and medicinal chemist with a passion for designing, synthesizing, and studying novel molecules with the potential to improve human health. Before leading the team at Function Therapeutics, he was a faculty member at Marquette University, where he led a team of scientists in developing new probe molecules and drug candidates through the modification and redesign of natural and unnatural compounds, as well as novel catalysts. He is the co-author of more than 60 scientific papers and patent applications, and is the inventor of parmodulin compounds and modified opioids presently under investigation for several indications. Previously, he was a scientist at the Broad Institute, the University of Texas at Austin, and NPS Pharmaceuticals. Chris obtained his B.Sc. from the University of Waterloo and his Ph.D. from the University of Toronto.